Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Are the Projected Expansion Rates of the Plasma Therapy Market for the Next Decade?

In the last few years, the plasma therapy market has seen significant expansion. The market, which was valued at $0.49 billion in 2024, is projected to increase to $0.55 billion in 2025, showing a compound annual growth rate (CAGR) of 11.4%. The growth during the historical period can be attributed to factors such as the increasing pervasiveness of chronic illnesses, a growing understanding of the advantages of plasma therapy, government backing for plasma therapy, reimbursement eligibility for plasma therapy procedures, a rising demand for less intrusive treatments, an incline in requests for tailored medicine, and a mounting elderly population.

In the ensuing years, the plasma therapy market is projected to witness an accelerated rate of growth. By 2029, it is anticipated to reach a market value of $0.88 billion, with a compound annual growth rate (CAGR) of 12.5%. The growth expected in this forecast period is due to factors such as the increased adoption of immunoglobulins, expanding applications, growing demand for the treatment of rare diseases, and personalized therapeutic approaches. Principal trends observed in this period encompass the evolution of novel and enhanced plasma therapy procedures, biological production, plasma therapies devoid of cells, the incorporation of telemedicine, and exploration into novel applications.

What Factors Are Propelling the Growth of the Plasma Therapy Market from 2025 to 2034?

As osteoarthritis cases increase, it is predicted to stimulate growth in the plasma therapy market throughout the forecasted timeline. One such type of plasma therapy, Platelet-rich plasma (PRP), is viewed as an effective and safe measure to treat osteoarthritis. PRP is a growth factor from one’s own blood, which is highly concentrated and administered through injections into the ailing joint, aiming to alleviate symptoms by reducing inflammation and decelerating osteoarthritis progress. For example, Journal of Elsevier, a Dutch publishing company, revealed in September 2023 that by 2050 the forecasted increase in osteoarthritis cases globally could reach 74.9% (from 59.4% to 89.9%) for knee arthritis, 48.6% (from 35.9% to 67.1%) for hand arthritis, 78.6% (from 57.7% to 105.3%) for hip arthritis, and 95.1% (from 68.1% to 135.0%) for other types of osteoarthritis. Among the most prevalent treatments for osteoarthritis are autologous chondrocyte implantation and scaffold implants. Consequently, a surge in osteoarthritis cases is anticipated to propel the plasma therapy market growth.

Explore Comprehensive Insights Into The Global Plasma Therapy Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3278&type=smp

Which Companies Are Redefining the Future of the Plasma Therapy Market?

Major companies operating in the plasma therapy market include Takeda Pharmaceutical Company Limited, Bio Products Laboratory Ltd., Arthrex Inc., Biotest AG, China Biologic Products Holdings Inc., DePuy Synthes Companies, CSL Limited, Grifols S.A., Octapharma AG, Terumo BCT Inc., Pfizer Inc., Kedrion Biopharma, ADMA Biologics Inc., SK Plasma Co. Ltd., Kamada Ltd., Fusion HealthCare, LFB Plasma, Baxter International Inc., Bayer AG, GC Biopharma Corp, Hualan Biological Engineering Inc., Japan Blood Products Organization, PlasmaCare Inc., ProMetic Life Sciences Inc., Sanquin, Shanghai RAAS Blood Products Co. Ltd., Canadian Plasma Resources, B Positive Plasma, Proesis Biologics Inc.

What Are the Most Prominent Trends Driving Change in the Plasma Therapy Market?

In tune with the changing needs of the plasma therapy market, leading companies are coming up with inventive products like the ESG-410, in a bid to increase treatment options. The ESG-410 is an Electrosurgical Generator created to add alternatives and efficiencies in the treatment of non-muscle-invasive bladder cancer (NMIBC) and benign prostatic hyperplasia. One instance occurred in June 2023 when Olympus Corporation, a medical technology company from Japan, introduced the subsequently improved version of the electrosurgical generator, ESG-410, which is utilized for bladder cancer and enlarged prostate treatment. The ESG-410 includes advanced features such as enhanced capacitors, ensuring excellent plasma stability at ignition. It provides quicker ignition and enhanced plasma stability, surpassing the capabilities of ESG-400 particularly when used with different loop sizes and oval buttons. The advanced ESG-410 Electrosurgical Generator expands treatment options for NMIBC and BPH by delivering a variety of resection loops, electrodes, and vaporization tools.

Secure Your Global Plasma Therapy Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/plasmas-therapy-global-market-report

How Are Key Segments Defining the Competitive Landscape of the Plasma Therapy Market?

The plasma therapy market covered in this report is segmented –

1) By Type: Pure PRP, Leukocyte-rich PRP, Pure Platelet-rich Fibrin (PRF), Leukocyte-rich Fibrin (L-PRF)

2) By Application: Orthopedics, Arthritis, Chronic Tendinitis, Bone Repair & Regeneration, Dermatology, Androgenic Alopecia, Plastic Surgery, Dental, Cardiac Muscle Injury, Other Applications

3) By End-Users: Hospitals & Clinics, Laboratories: Research Institutes

Subsegments:

1) By Pure PRP: High Concentration PRP, Low Concentration PRP

2) By Leukocyte-Rich PRP: PRP With White Blood Cells, PRP With Growth Factors

3) By Pure Platelet-rich Fibrin (PRF): Injectable PRF, Membrane PRF

4) By Leukocyte-rich Fibrin (L-PRF): L-PRF Clots, L-PRF Membranes

What Are the Leading Regions in the Plasma Therapy Market Expansion?

The countries covered in the plasma therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

How Is the Plasma Therapy Market Classified and Defined in Market Analysis?

Plasma therapy refers to a treatment that substitutes missing or inadequate proteins to help people live healthier and more fruitful lives. It introduces antibodies into individuals receiving therapy using blood donated by recovered patients.

Browse Through More Similar Reports By The Business Research Company:

Blood Transfusion Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

Apheresis Consumables And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/apheresis-consumables-and-equipment-global-market-report

Hematology Analyzers and Reagents Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hematology-analyzers-and-reagents-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: